Loading...
Loading...
Pharmacyclics Inc.
PCYC will get acquired by Johnson & Johnson
JNJ according to an unconfirmed report Wednesday by Bloomberg.
The report, citing unnamed sources, said Pharmacyclics may fetch up to $18 billion in a sales agreement that could get unveiled Thursday.
Pharmacyclics market capitalization as of Wednesday is $16.54 billion.
The Sunnyvale, California-based cancer drug maker changed hands in the extended session recently at $236.98, after closing at $230.48. The shares are up more than 40 percent during the past month.
Bloomberg reported Feb. 25 that Pharmacyclics was considering a sale and had obtained interest from both Johnson & Johnson as well as Novartis AG
NVS.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in